Northern Data AG · ISIN: DE000A0SMU87 · Directors Dealings
Insider Transaction Snapshot

Northern Data AG

Directors Dealings: 15th August 2025
Reporting obligation triggered by: ART Beteiligungs Management GmbH
Trading volume: 100.669.593,00 EUR
Type: not specified

The Insider Transaction was made by ART Beteiligungs Management GmbH . The transaction toke place on 11th August 2025. The aggregated volume was 100.669.593,00 EUR, based on an average price of 22,94 EUR. The nature of the Investment was not specified.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

08 July 2022
VERBIO Vereinigte BioEnergie AG: A reportable insider transaction was published on 7th July 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 7th July 2022,

The Insider Transaction was made by Sauter, Bernd . The transaction toke place on 6th July 2022. . The aggregated volume was 2.249.066,04 EUR, based on an average price of 53,58 EUR. The nature of the Investment was not specified.

VERBIO Vereinigte BioEnergie AG
30 June 2022
SÜSS MicroTec SE: A reportable insider transaction was published on 30th June 2022. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 30th June 2022,

The Insider Transaction was made by Schulte, Dr. Bernd . The transaction toke place on 29th June 2022. The order was executed at the trading place XETRA. . The aggregated volume was 157.225,24 EUR, based on an average price of 14,29 EUR. The nature of the Investment was Buy.

SÜSS MicroTec SE
30 June 2022
SÜSS MicroTec SE: A reportable insider transaction was published on 30th June 2022. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 30th June 2022,

The Insider Transaction was made by Schulte, Dr. Bernd . The transaction toke place on 28th June 2022. The order was executed at the trading place XETRA. . The aggregated volume was 158.598,60 EUR, based on an average price of 14,42 EUR. The nature of the Investment was Sell.

SÜSS MicroTec SE
29 June 2022
Knorr-Bremse Aktiengesellschaft: A reportable insider transaction was published on 29th June 2022. The reporting obligation was triggered by a person related to Management Board.

Transaction reporting date: 29th June 2022,

The Insider Transaction was made by Spies, Bernd . The transaction toke place on 24th June 2022. The order was executed at the trading place Börse München. . The aggregated volume was 39.987,60 EUR, based on an average price of 56,40 EUR. The nature of the Investment was Buy.

Knorr-Bremse Aktiengesellschaft
03 June 2022
Belano Medical AG: A reportable insider transaction was published on 1st June 2022. The reporting obligation was triggered by a person related to Management Board.
DE000A3H2UW2

Transaction reporting date: 1st June 2022,

The Insider Transaction was made by Wegener, Dr Bernd . The transaction toke place on 24th May 2022. . The aggregated volume was 100.000,00 EUR, based on an average price of 100,00 EUR. The nature of the Investment was Buy.

Belano Medical AG
31 May 2022
SANHA GmbH & Co. KG: A reportable insider transaction was published on 30th May 2022. The reporting obligation was triggered by a person related to Other executive.

Transaction reporting date: 30th May 2022,

The Insider Transaction was made by Kaimer, Bernd . The transaction toke place on 26th May 2022. . The aggregated volume was 14.200,00 EUR, based on an average price of 710,00 EUR. The nature of the Investment was Buy.

SANHA GmbH & Co. KG
29 April 2022
Belano Medical AG: A reportable insider transaction was published on 28th April 2022. The reporting obligation was triggered by a person related to Management Board.
DE000A3H2UW2

Transaction reporting date: 28th April 2022,

The Insider Transaction was made by Wegener, Dr Bernd . The transaction toke place on 28th April 2022. . The aggregated volume was 150.000,00 EUR, based on an average price of 100,00 EUR. The nature of the Investment was Buy.

Belano Medical AG
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html